Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

pembrolizumab 438 Carboplatin 322 Nivolumab 286 Cyclophosphamide 280 Specimen Handling 257 Cisplatin 252 Paclitaxel 249 Magnetic Resonance Spectroscopy 248 Radiotherapy 217 Gemcitabine 180 Dexamethasone 180 Biopsy 177 durvalumab 167 atezolizumab 148 Rituximab 138 Lenalidomide 134 Doxorubicin 134 Docetaxel 130 Bevacizumab 129 Ipilimumab 125 Radiation 118 Capecitabine 117 Pemetrexed 113 Oxaliplatin 112 Etoposide 111 Radiosurgery 109 venetoclax 108 Fluorouracil 108 fludarabine 106 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × artenimol × Clear all

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡